Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: Interferon Gamma-1b in Friedreich Ataxia (FRDA) [Phase 2]

View source ↗

Summary

Phase 2 trial of Interferon Gamma-1b in Friedreich Ataxia completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED | Results posted: 2015-04-30